首页 > 市场调查报告书 > 医疗设备

体外诊断

乳胶过敏市场规模、份额和成长分析（按诊断类型、暴露类型、反应类型、治疗类型、应用和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902032

乳胶过敏市场规模、份额和成长分析（按诊断类型、暴露类型、反应类型、治疗类型、应用和地区划分）－2026-2033年产业预测

Latex Allergy Market Size, Share, and Growth Analysis, By Diagnosis Type (Allergy Test, Skin Test), By Exposure Type, By Reaction Type, By Treatment Type, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 220 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球乳胶过敏市场规模将达到 18.3 亿美元，到 2025 年将达到 19.6 亿美元，到 2033 年将达到 35 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.5%。

受一次性乳胶製品消费量不断增长的推动，全球乳胶过敏市场预计将迎来显着成长。乳胶过敏是由接触天然橡胶乳胶引起的，会引发免疫反应，将无害蛋白质误认为潜在威胁。这会导致抗体和抗组织胺物质的释放，进而引发搔痒、皮疹、荨麻疹和湿疹等症状，进一步加重皮肤状况。乳胶过敏的发生率在经常使用乳胶製品的人群中尤其显着，并导致气喘和鼻炎等相关疾病的发生率上升。人们对这些健康问题的日益关注以及对乳胶製品依赖性的增强，推动了市场显着增长，凸显了对有效管理方法和替代方案的迫切需求。

全球乳胶过敏市场成长要素

推动全球乳胶过敏市场成长的关键因素是全球乳胶过敏发生率的上升。这一激增归因于人们接触乳胶产品的机会增多，尤其是在医疗机构中，以及公众对该疾病的意识提高。此外，诊断技术的进步提高了乳胶过敏的识别和检测准确性，进一步促进了市场扩张。随着公众意识的增强和确诊病例的增加，市场对有效解决方案和管理方案的需求预计将进一步增长，凸显了创新和支持的重要性。

限制全球乳胶过敏市场发展的因素

全球乳胶过敏市场面临的主要挑战之一是乳胶过敏诊断和治疗的高成本。诸如特异性IgE检测和现代皮肤点刺试验等先进诊断方法往往价格昂贵，这可能会限制低收入地区人口获得这些服务的机会。这种经济障碍削弱了全面过敏管理方案的普及，并阻碍了整体市场成长。因此，不断上涨的成本造成了获得必要医疗保健的机会不均等，限制了受影响人群及时获得诊断和有效治疗的能力，最终阻碍了全球乳胶过敏市场的扩张。

全球乳胶过敏市场趋势

全球乳胶过敏市场正经历医疗保健领域意识的不断提高，并显着转向预防策略。乳胶过敏的普遍性，尤其是在医护人员、手术病患以及经常接触含乳胶医疗设备的人中，促使医疗机构采用更安全的替代方案和更严格的通讯协定。随着医疗界日益重视患者和员工的安全，对非乳胶产品的需求激增，推动了材料创新并加强了法规结构。这种对过敏反应日益增长的关注，营造了一种以最大限度减少医疗保健应用中乳胶暴露为核心的新氛围。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Ansell Limited（Australia）
Top Glove Corporation Bhd（Malaysia）
Hartalega Holdings Berhad（Malaysia）
Supermax Corporation Berhad（Malaysia）
Cardinal Health（USA）
Medline Industries, LP（USA）
Semperit AG Holding（Austria）
Thermo Fisher Scientific（USA）
Siemens Healthineers AG（Germany）
Danaher Corporation（USA）
ALK-Abello A/S（Denmark）
Mylan NV（now Viatris Inc.）（USA）
Sanofi SA（France）
GlaxoSmithKline plc（UK）

结论与建议

简介目录

Product Code: SQMIG35I2328

Global Latex Allergy Market size was valued at USD 1.83 Billion in 2024 and is poised to grow from USD 1.96 Billion in 2025 to USD 3.5 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global latex allergy market is poised for substantial growth, driven by the rising consumption of latex disposable products. This allergy stems from exposure to natural rubber latex, leading to an immune response characterized by the body identifying harmless proteins as potential threats. Consequently, antibodies and antihistamines are released, resulting in symptoms such as itching, rashes, hives, and eczema, which can further exacerbate skin conditions. The growing prevalence of latex allergies is especially notable in populations regularly using latex products, contributing to increased incidents of related conditions like asthma and rhinitis. As awareness of these health issues expands, alongside a greater reliance on latex supplies, the market is witnessing a significant upward trajectory, underscoring an urgent need for effective management and alternatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Latex Allergy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Latex Allergy Market Segments Analysis

Global Latex Allergy Market is segmented by Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application and region. Based on Diagnosis Type, the market is segmented into Allergy Test and Skin Test. Based on Exposure Type, the market is segmented into Food Containing Latex Substances, Latex Gloves and Others. Based on Reaction Type, the market is segmented into Allergic Contact Dermatitis, Synthetic Reaction and Others. Based on Treatment Type, the market is segmented into Allergy Medication and Epinephrine Injection. Based on Application, the market is segmented into Allergic Contact Dermatitis, Systemic Reaction and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Latex Allergy Market

A significant factor propelling the growth of the global latex allergy market is the rising incidence of latex allergies across the globe. This surge can be attributed to heightened exposure to latex products, particularly in healthcare environments, combined with growing public awareness about the condition. Additionally, advancements in diagnostic techniques have led to improved identification and detection of latex allergies, further contributing to the market's expansion. As awareness continues to rise and more individuals are diagnosed, the demand for effective solutions and management options in the latex allergy market is expected to grow, reflecting a critical need for innovation and support.

Restraints in the Global Latex Allergy Market

One significant challenge facing the global latex allergy market is the high cost associated with the diagnosis and treatment of latex allergies. Advanced diagnostic methods, such as targeted IgE testing and modern skin prick tests, tend to be expensive, which can restrict access for individuals in lower-income regions. This financial barrier undermines the availability of comprehensive allergy management programs, thereby hindering overall market growth. Consequently, the elevated costs create disparities in access to necessary medical care, limiting the ability of affected individuals to receive timely diagnoses and effective treatments, and ultimately impeding the expansion of the latex allergy market on a global scale.

Market Trends of the Global Latex Allergy Market

The Global Latex Allergy market is witnessing a notable shift towards heightened awareness and preventive strategies within healthcare settings. The prevalence of latex allergies, particularly among healthcare professionals, surgical patients, and those frequently exposed to latex-containing medical equipment, is prompting institutions to adopt safer alternatives and stringent protocols. As the medical community increasingly prioritizes patient and staff safety, demand for non-latex products is surging, driving innovations in materials and strengthening regulatory frameworks. This growing concern for allergic reactions is fostering an environment where proactive measures are essential, leading to a redefined landscape focused on minimizing latex exposure across healthcare applications.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Latex Allergy Market Size by Diagnosis Type & CAGR (2026-2033)

Market Overview
Allergy Test
Skin Test

Global Latex Allergy Market Size by Exposure Type & CAGR (2026-2033)

Market Overview
Food Containing Latex Substances
Latex Gloves
Others

Global Latex Allergy Market Size by Reaction Type & CAGR (2026-2033)

Market Overview
Allergic Contact Dermatitis
Synthetic Reaction
Others

Global Latex Allergy Market Size by Treatment Type & CAGR (2026-2033)

Market Overview
Allergy Medication
Epinephrine Injection

Global Latex Allergy Market Size by Application & CAGR (2026-2033)

Market Overview
Allergic Contact Dermatitis
Systemic Reaction
Others

Global Latex Allergy Market Size & CAGR (2026-2033)

North America (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- US
- Canada
Europe (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Ansell Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Top Glove Corporation Bhd (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hartalega Holdings Berhad (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Supermax Corporation Berhad (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, LP (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Semperit AG Holding (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALK-Abello A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (now Viatris Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments